Shrutih Tewarie

Apr 3, 2024 | mondaq.com | Brian Carey |Sarah Cooleybeck |Shrutih Tewarie |Patrick Brennan

Bipartisan legislation moving through the U.S. House and Senate, known as the BIOSECURE Act, could limit the ability of U.S. life sciences companies to contract with biotechnology companies with ties to the Chinese government or another "foreign adversary." The potentially broad scope of the legislation would both prohibit the U.S. government from contracting with a "biotechnology company of concern," as well as prevent companies that contract with or receive funding from the federal...

Oct 13, 2023 | jdsupra.com | Shrutih Tewarie

Oct 2, 2023 | jdsupra.com | Luciano Racco |Shrutih Tewarie

As the standoff in Congress on the budget threatens to shut down vast swaths of the federal government, we write to remind clients about how a federal government shutdown would affect international trade and investment.

Oct 2, 2023 | mondaq.com | Luciano Racco |Shrutih Tewarie

As the standoff in Congress on the budget threatens to shut down vast swaths of the federal government, we write to remind clients about how a federal government shutdown would affect international trade and investment.

Apr 4, 2023 | lexblog.com | Shrutih Tewarie

Key TakeawaysDOJ continues to focus on corporate self-disclosure and remediation, individual accountability, and international cooperation on corruption matters.